Quest Diagnostics Incorporated – Consensus Indicates Potential 18.1% Upside
Quest Diagnostics Incorporated found using ticker (DGX) now have 14 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 160 and 129 with a mean TP of 144.5. Now with the previous closing price of 122.35 this would indicate that there is a potential upside of 18.1%. The 50 day MA is 131.67 and the 200 moving average now moves to 138.54. The market capitalisation for the company is $14,366m. Visit the company website at: https:||www.questdiagnostics.com [stock_market_widget type="chart" template="basic" color="green" assets="DGX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $16,967m based on the market concensus. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Quest Diagnostics Incorporated – Consensus Indicates Potential 18.1% Upside
Quest Diagnostics Incorporated found using ticker (DGX) now have 14 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 160 and 129 with a mean TP of 144.5. Now with the previous closing price of 122.35 this would indicate that there is a potential upside of 18.1%. The 50 day MA is 131.67 and the 200 moving average now moves to 138.54. The market capitalisation for the company is $14,366m. Visit the company website at: https:||www.questdiagnostics.com [stock_market_widget type="chart" template="basic" color="green" assets="DGX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $16,967m based on the market concensus. Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.